Navigation Links
Nektar Therapeutics Reports Fourth Quarter and Year-End 2012 Financial Results
Date:2/28/2013

ose indicated in the forward-looking statements include, among others, (i) our drug candidates and those of our collaboration partners are in various stages of clinical development and the risk of failure is high and can unexpectedly occur at any stage prior to regulatory approval for numerous reasons including safety and efficacy findings even after positive findings in previous preclinical and clinical studies; (ii) the timing of the commencement or end of clinical trials and the commercial launch of our drug candidates may be delayed or unsuccessful due to regulatory delays, slower than anticipated patient enrollment, manufacturing challenges, changing standards of care, evolving regulatory requirements, clinical trial design, clinical outcomes, competitive factors, or delay or failure in ultimately obtaining regulatory approval in one or more important markets; (iii) acceptance, review and approval decisions for new drug applications by health authorities is an uncertain and evolving process and health authorities retain significant discretion at all stages of the regulatory review and approval decision process; (iv) scientific discovery of new medical breakthroughs is an inherently uncertain process and the future success of the application of our technology platform to potential new drug candidates is therefore highly uncertain and unpredictable and one or more research and development programs could fail; and (v) certain other important risks and uncertainties set forth in our Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 9, 2012. Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.Nektar Investo
'/>"/>
SOURCE Nektar Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Nektar To Host Conference Call To Discuss The Positive Phase 3 Clinical Results For Naloxegol
2. Nektar Announces that FDA Grants Fast Track Designation to Etirinotecan Pegol (NKTR-102) for the Treatment of Metastatic Breast Cancer
3. Nektar to Announce Financial Results for the Third Quarter of 2012 On Tuesday, November 13, 2012, After Close of U.S.-Based Financial Markets
4. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the UBS 2012 Global Life Sciences Conference in New York City
5. Nektar Therapeutics Reports Financial Results for the Second Quarter of 2012
6. Nektar Announces Initiation of Investigator-Sponsored Trial Evaluating Etirinotecan Pegol (NKTR-102) in Patients with Bevacizumab (Avastin)-resistant High-Grade Glioma
7. Nektar Announces Start of Enrollment in Phase 2 Study of NKTR-181, a Novel Opioid Analgesic Molecule, for Treatment of Chronic Pain
8. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
9. Nektar Therapeutics President and CEO Howard W. Robin to Present at the Jefferies 2012 Global Healthcare Conference in New York
10. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
11. Nektar to Announce Financial Results for the First Quarter of 2012 on Wednesday, May 2, 2012, After Close of U.S.-Based Financial Markets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014 Decision Resources Group ... the Memphis health system and ... clinical integration, with rivals Methodist Le Bonheur Healthcare and ... groups to coordinate patient care. In addition, a national ... the most health plan enrollment in the ...
(Date:8/27/2014)... 2014 ResearchMoz presents this most ... Market Outlook to 2020. New report, "United States Laparoscopes ... the United States Laparoscopes market . The report ... units) and average prices (in US dollars) within market ... Tip Video Laparoscopes), Robotic Surgical Systems and Rigid Tip ...
(Date:8/27/2014)... WASHINGTON , Aug. 27, 2014 An experimental ... promise as a viable first treatment for anemia of inflammation, ... of the treatment published online today in Blood ... Hematology (ASH).    Anemia is a condition ... or do not function properly. When an individual has anemia, ...
Breaking Medicine Technology:Memphis-area Health Systems Turn Attention to Clinical Integration 2United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 2United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 3United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 4United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 5Drug Represents First Potential Treatment for Common Anemia 2Drug Represents First Potential Treatment for Common Anemia 3
... 11 BioStorage Technologies, a global leader in ... for the pharmaceutical and biotechnology industries, has expanded ... preparation services, including sample aliquoting and nucleic acid ... for comprehensive sample management continues to grow, BioStorage ...
... Oct. 11 CEL-SCI Corp. (Amex: CVM ) ... Virtual ConferenceWhen: , October 13, 2010 @ 11:30 AM ... the Internet -- Simply log on to the web at ... If you are unable to participate during the live webcast, ...
Cached Medicine Technology:Industry Leader BioStorage Technologies Broadens Sample Management Operations to Include Laboratory Sample Preparation Services 2
(Date:8/28/2014)... 28, 2014 Now in its 4th year, ... started in 2011 by two brain aneurysm survivors. The ongoing ... awareness, provide education to help increase early detection and to ... a brain aneurysm. We hope that you will be able ... at the 4th Annual Step for Hope Run/ Walk on ...
(Date:8/28/2014)... MMAR Medical is pleased to announce their ... regular customers to enjoy several perks and benefits when ... wholesale license. It’s a great choice for independent athletes, ... who regularly purchase medical braces but could use a ... active lifestyle or those of your club, group or ...
(Date:8/28/2014)... 28, 2014 The revenue cycle process ... from the time a patient books an appointment with ... provide final payments for services rendered to the healthcare ... billing service has the RCM process down to a ... computers become common place in nearly every healthcare facility ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 UniVoIP, Inc, ... El Segundo, CA, today announced that they have been ... of Los Angeles Local Small Business Enterprise (Local SBE) ... and certified by the state of California and LA ... Cloud-hosted Telephony Solution to governmental agencies throughout ...
(Date:8/27/2014)... (PRWEB) August 28, 2014 Author and ... iUniverse) takes readers on the thrilling adventures of sharp ... published in 2012, is gearing up for a new ... Split into two novellas , “Prescription: Murder” follows ... who finds himself dodging assassination attempts and thwarting criminals. ...
Breaking Medicine News(10 mins):Health News:Step for Hope and Raise Brain Aneurysm Awareness 2Health News:MMAR Medical Announces Customer Membership Program 2Health News:Tips on Automating the Revenue Cycle Process with Medical Billing 2Health News:Tips on Automating the Revenue Cycle Process with Medical Billing 3Health News:Cloud PBX Provider UniVoIP Gets Certified by the State of California and the County of Los Angeles Under the Local Small Business Enterprise (SBE) Preference Program 2Health News:William H. Simon Launches New Marketing Campaign for Book 2
... the brain called the choroid plexus that ostensibly possesses ... protein, associated with Alzheimer’s disease.// ,The ... protein, called beta-amyloid, and prevents it from accumulating in ... cord. Wei Zheng, an associate professor in the School ...
... a recent research, Angina, a from of heart disease that ... the fair sex//. Angina can cause heart attacks. ,Angina ... triggered by deficiency in oxygen that is carried to the ... narrowing of coronary arteries. Exercise, cold or emotional stress can ...
... on the newer medications for diabetics had a slightly ... and $1,760 less on annual total healthcare costs. ... the Merrell Dow professor of pharmacy at Ohio State ... data on patients who took thiazolidinediones (TZDs) or either ...
... breast cancer found a savior in her daughter, who helped ... Herceptin could be made available for her to fight debilitating ... the cancer drug to Mrs. Morgan, of Whitchurch. Katie Morgan, ... Owen Paterson, and expressed her mother’s condition, petitioning for humanitarian ...
... one of the deadliest diseases in UK. Symptoms include a ... to rush to the loo//. ,Hence DUP MP ... awareness about prostate cancer. Prostate cancer kills 220 men in ... ,Mr Campbell has won the support of 55 ...
... to sleep more and more and just can’t seem to ... the University of Athens//, one among four adults and one ... of snooze time every night. ,Psychiatry professor and head ... “We spend 20 percent less time sleeping now than 100 ...
Cached Medicine News:Health News:Angina Risks Pronounced In Women over 45 2Health News:New Diabetic Drugs More Effective than Older Ones 2
The perfect quick consult for the busy cardiologist, The Ultimate Echo Guide puts the most clinically essential information in an easy access format....
... a quick-lookup reference for ECG interpretation ... presents the basics (anatomy and physiology ... system of the heart, basic ECG ... algorithms, emergency medications, and comprehensive information ...
Dx/Rx: Heart Failure has tables and figures that summarize important clinical data and current professional society recommendations and up-to-date information for diagnosis and treatment of Heart Fai...
Topics include: ECG reading, ACLS (all the latest protocols and pearls), CHF, acute MI, cardiac testing, palpitations, pericarditis, arrhythmias, murmurs, athletes, valvular disease, endocarditis, sy...
Medicine Products: